Abstract
Anxiety disorders in childhood are quite common, affecting between 6 and 20% of all children (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Anxiety disorders can adversely impact social and academic functioning as well as self-esteem (Mendlowicz & Stein, 2000). Children with anxiety disorders grow up to having greater rates of depression, new anxiety disorders, substance abuse, educational underachievement, and suicide attempts than the general population (Achenbach, Howell, McConaughy, & Stanger, 1995; Ferdinand, Verhulst, & Wiznitzer, 1995; Pine, Cohen, Gurley, Brook, & Ma, 1998; Woodward & Fergusson, 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aaron, J., Zaglul, H., & Emery, R. E. (1999). Posttraumatic stress in children following acute physical injury. Journal of Pediatric Psychology, 24(4), 335–343.
Achenbach, T. M., Howell, C. T., McConaughy, S. H., & Stanger, C. (1995). Six-year predictors of problems in a national sample: III. Transitions to young adult syndromes. Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 658–669.
Ahmad, A., Larsson, B., & Sundelin-Wahlsten, V. (2007). EMDR treatment for children with PTSD: Results of a randomized controlled trial. Nordic Journal of Psychiatry, 61(5), 349–354.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.
Barbanti, P., & Fabbrini, G. (2004). Migraine and Tourette syndrome. Archives of Neurology, 61(4), 606–607; author reply 607.
Beidel, D. C., Turner, S. M., Sallee, F. R., Ammerman, R. T., Crosby, L. A., & Pathak, S. (2007). SET-C versus fluoxetine in the treatment of childhood social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 46(12), 1622–1632.
Birmaher, B., Axelson, D. A., Monk, K., Kalas, C., Clark, D. B., Ehmann, M., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 415–423.
Bloch, M. H., Craiglow, B. G., Landeros-Weisenberger, A., Dombrowski, P. A., Panza, K. E., Peterson, B. S., et al. (2009). Predictors of early adult outcome in pediatric-onset obsessive-compulsive disorder. Pediatrics, 124(4), 1085–1093.
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M. B., & Leckman, J. F. (2006). A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry, 11(7), 622–632.
Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F., & Pittenger, C. P. (2010). Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry, 15(8), 850–855.
Bollini, P., Pampallona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999). Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. The British Journal of Psychiatry, 174, 297–303.
Brady, K. T., Pearlstein, T., & Asnis, G. M. (2000). Double-blind, placebo-controlled study of the efficacy and safety of sertraline for posttraumatic stress disorder. JAMA, 283, 545–554.
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297(15), 1683–1696.
Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 393–402.
Cohen, J. A., Mannarino, A. P., & Deblinger, E. (2006). Treating trauma and traumatic grief in children and adolescents. New York: Guilford.
Cohen, J. A., Mannarino, A. P., Perel, J. M., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 811–819.
Connolly, S. D., & Bernstein, G. A. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46(2), 267–283.
Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., & Davidson, J. R. (1999). Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. The British Journal of Psychiatry, 175, 17–22.
Costello, E. J., Erkanli, A., Fairbank, J. A., & Angold, A. (2002). The prevalence of potentially traumatic events in childhood and adolescence. Journal of Traumatic Stress, 15(2), 99–112.
Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60(8), 837–844.
Ferdinand, R. F., Verhulst, F. C., & Wiznitzer, M. (1995). Continuity and change of self-reported problem behaviors from adolescence into young adulthood. Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 680–690.
Fineberg, N. A., Pampaloni, I., Pallanti, S., Ipser, J., & Stein, D. J. (2007). Sustained response versus relapse: The pharmacotherapeutic goal for obsessive-compulsive disorder. International Clinical Psychopharmacology, 22(6), 313–322.
Finkelhor, D., Hamby, S. L., Ormrod, R., & Turner, H. (2005). The Juvenile Victimization Questionnaire: Reliability, validity, and national norms. Child Abuse & Neglect, 29(4), 383–412.
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., et al. (2003). Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child and Adolescent Psychopharmacology, 13(Suppl 1), S19–S29.
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry, 160(11), 1919–1928.
Geller, D. A., Hoog, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(7), 773–779.
Gellar, D. A., Wagner, K. D., Emslie, G., Murphy, T., Carpenter, D. J., Wetherhold, E., Perera, P., Machin, A., Garnier, C. (2004). Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 43(11), 1387–1396.
Goodman, W. K., Murphy, T. K., & Storch, E. A. (2007). Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl), 191(1), 87–96.
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry, 46(11), 1012–1016.
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006–1011.
Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33(3), 372–376.
Greist, J. H., Bandelow, B., Hollander, E., Marazziti, D., Montgomery, S. A., Nutt, D. J., et al. (2003). WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectrums, 8(8 Suppl 1), 7–16.
Hammad, T. A. (2004). Review and evaluation of clinical data. Washington, DC, Food and Drug Administration, Aug 16,2004. Http://www.fda.gov/ohrms/dockets/ac/04/.
Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35(9), 1247–1249.
Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., & Burnham, D. B. (2003). Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. The Journal of Clinical Psychiatry, 64(9), 1113–1121.
Horrigan, J. P. (1996). Guanfacine for PTSD nightmares. Journal of the American Academy of Child and Adolescent Psychiatry, 35(8), 975–976.
Kashani, J. H., & Orvaschel, H. (1990). A community study of anxiety in children and adolescents. The American Journal of Psychiatry, 147(3), 313–318.
Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52(12), 1048–1060.
Lieberman, A. F., Van Horn, P., & Ippen, C. G. (2005). Toward evidence-based treatment: Child-parent psychotherapy with preschoolers exposed to marital violence. Journal of the American Academy of Child and Adolescent Psychiatry, 44(12), 1241–1248.
Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R., & Pitts, C. D. (2002). A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. The Journal of Clinical Psychiatry, 63(1), 66–74.
March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA, 280(20), 1752–1756.
March, J. S., Entusah, A. R., Rynn, M., Albano, A. M., & Tourian, K. A. (2007). A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biological Psychiatry, 62(10), 1149–1154.
March, J. S., Parker, J. D., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 554–565.
Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., & Leslie, D. (2004). Age effects on antidepressant-induced manic conversion. Archives of Pediatrics & Adolescent Medicine, 158(8), 773–780.
Mendlowicz, M. V., & Stein, M. B. (2000). Quality of life in individuals with anxiety disorders. The American Journal of Psychiatry, 157(5), 669–682.
Nader, K. O., Kriegler, J. A., Blake, D. D., Pynoos, R. S., Newman, E., & Weathers, F. W. (1996). Clinician administered PTSD Scale for children and adolescents for DSM-IV. Los Angeles, CA: National Center for PTSD and UCLA Trauma Psychiatry Program, Department of Psychiatry, UCLA School of Medicine.
Najavits, L. M., Gallop, R. J., & Weiss, R. D. (2006). Seeking safety therapy for adolescent girls with PTSD and substance use disorder: A randomized controlled trial. The Journal of Behavioral Health Services & Research, 33(4), 453–463.
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., et al. (2002). Treatment non-response in OCD: Methodological issues and operational definitions. The International Journal of Neuropsychopharmacology, 5(2), 181–191.
Pine, D. S., & Cohen, J. A. (2002). Trauma in children and adolescents: Risk and treatment of psychiatric sequelae. Biological Psychiatry, 51(7), 519–531.
Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998). The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry, 55(1), 56–64.
POTS. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA, 292, 1969–1976.
Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. Retrieved February 28, 2010, from http://www.aacap.org/galleries/PracticeParameters/Final%20for%20Web%20December%202009%20PTSD.pdf
Reich, D. B., Winternitz, S., Hennen, J., Watts, T., & Stanculescu, C. (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. The Journal of Clinical Psychiatry, 65(12), 1601–1606.
Reinblatt, S. P., & Walkup, J. T. (2005). Psychopharmaco-logic treatment of pediatric anxiety disorders. Child and Adolescent Psychiatric Clinics of North America, 14(4), 877–908, x.
Research Unit on Pediatric Psychopharmacology Anxiety Study Group, Fluvoxamine for the treatment of anxiety disorders in children and adolescents, N Engl J Med 344 (2001), pp. 1279–1285.
Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 222–229.
Robb, A., Cueva, J., Sporn, J., Yang, R., & Vanderburg, D. (2008). Efficacy of sertraline in childhood posttraumatic stress disorder. Paper presented at the American Academy of Child and Adolescent Psychiatry, Chicago, IL.
Rothbaum, B. O., Kozak, M. J., Foa, E. B., & Whitaker, D. J. (2001). Posttraumatic stress disorder in rape victims: Autonomic habituation to auditory stimuli. Journal of Traumatic Stress, 14(2), 283–293.
Rupp (2001). Research Unit on Pediatric Psychopharmacology Anxiety Study Group, Fluvoxamine for the treatment of anxiety disorders in children and adolescents, N Engl J Med 344, pp.1279–1289
Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American Journal of Psychiatry, 158(12), 2008–2014.
Rynn, M. A., Riddle, M. A., Yeung, P. P., Kunz, N. R. (2007). Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry. 164(2), 290–300.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844–852.
Scheeringa, M. S., Zeanah, C. H., Myers, L., & Putnam, F. W. (2003). New findings on alternative criteria for PTSD in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 42(5), 561–570.
Simeon, J. G., Ferguson, H. B., Knott, V., Roberts, N., Gauthier, B., Dubois, C., et al. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31(1), 29–33.
Simpson, H. B., Foa, E. B., Liebowitz, M. R., Ledley, D. R., Huppert, J. D., Chaill, S., et al. (2008). A randomized, controlled trail of cognitie-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry. 165(5), 621–30.
Stathis, S., Martin, G., & McKenna, J. G. (2005). A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center. Journal of Clinical Psychopharmacology, 25(6), 539–544.
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study. The American Journal of Psychiatry, 159(10), 1777–1779.
Steinberg, A. M., Brymer, M. J., Decker, K. B., & Pynoos, R. S. (2004). The University of California at Los Angeles Post-traumatic Stress Disorder Reaction Index. Current Psychiatry Reports, 6(2), 96–100.
The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344(17), 1279–1285.
Trowell, J., Kolvin, I., Weeramanthri, T., Sadowski, H., Berelowitz, M., Glaser, D., et al. (2002). Psychotherapy for sexually abused girls: Psychopathological outcome findings and patterns of change. The British Journal of Psychiatry, 180, 234–247.
van der Kolk, B. A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., et al. (1994). Fluoxetine in posttraumatic stress disorder. The Journal of Clinical Psychiatry, 55(12), 517–522.
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., et al. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Archives of General Psychiatry, 61(11), 1153–1162.
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. The New England Journal of Medicine, 359(26), 2753–2766.
Woodward, L. J., & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40(9), 1086–1093.
Acknowledgments
The authors acknowledge the National Institute of Mental Health support of the Yale Child Study Center Research Training Program (MHB), NARSAD (MHB), Trichotillomania Learning Center (MHB), the National Institutes of Health Loan Repayment Program (MHB), and the APIRE/Eli Lilly Psychiatric Research Fellowship (MHB).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bloch, M.H., McGuire, J.F. (2011). Pharmacological Treatment for Phobias and Anxiety Disorders. In: McKay, D., Storch, E. (eds) Handbook of Child and Adolescent Anxiety Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7784-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7784-7_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7782-3
Online ISBN: 978-1-4419-7784-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)